Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer and Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A.

Authors :: Moy B
Wolff AC
Rumble RB
Allison KH
Carey LA
Source :: JCO oncology practice [JCO Oncol Pract] 2023 Aug; Vol. 19 (8), pp. 547-550. Date of Electronic Publication: 2023 Jun 07.
Publication Year :: 2023

Subjects :: Humans
Female
Receptor, ErbB-2 therapeutic use
Hormones therapeutic use
Breast Neoplasms drug therapy
Breast Neoplasms pathology

Full Text Access

Tools